Clinical Trial Update: Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether the Aridol inhalation challenge can predict which COPD patients will respond to inhaled corticosteroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aridol (mannitol)
• Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: Syntara | Conditions: Lung Diseases, Obstructive | Phase 2 | Status: COMPLETED